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ABSTRACT 
Objectives To describe the prevalence rates of revision 
surgery for the treatment of prosthetic joint infection 
(PJI) for patients undergoing knee replacement, their 
time trends, the cumulative incidence function of 
revision for PJI and estimate the burden of PJI at health 
service level.
Design We analysed revision knee replacements 
performed due to a diagnosis of PJI and the linked 
index procedures recorded in the National Joint Registry 
from 2003 to 2014 for England and Wales. The cohort 
analysed consisted of 679 010 index primary knee 
replacements, 33 920 index revision knee replacements 
and 8247 revision total knee replacements performed 
due to a diagnosis of PJI. The prevalence rates, their 
time trends investigated by time from index surgery 
to revision for PJI, cumulative incidence functions and 
the burden of PJI (total procedures) were calculated. 
Overall linear trends were investigated with log-linear 
regression.
Results The incidence of revision total knee replacement 
due to PJI at 2 years was 3.2/1000 following primary 
and 14.4/1000 following revision knee replacement, 
respectively. The prevalence of revision due to PJI in 
the 3 months following primary knee replacement has 
risen by 2.5-fold (95% CI 1.2 to 5.3) from 2005 to 2013 
and 7.5-fold (95% CI 1.0 to 56.1) following revision 
knee replacement. Over 1000 procedures per year are 
performed as a consequence of knee PJI, an increase of 
2.8 from 2005 to 2013. Overall, 75% of revisions were 
two-stage with an increase in use of single-stage from 
7.9% in 2005 to 18.8% in 2014.
Conclusions Although the risk of revision due to PJI 
following knee replacement is low, it is rising, and coupled 
with the established and further predicted increased 
incidence of both primary and revision knee replacements, 
this represents an increasing and substantial treatment 
burden for orthopaedic service delivery in England and 
Wales. This has implications for future service design and 
the funding of individual and specialist centres.
Background
Deep prosthetic joint infection (PJI) is a 
rare but serious complication of total knee 
replacement. Patients experience severe 
pain, functional difficulties, poor quality 
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Strengths and limitations of this study
 ► This study provides updated and nationally 
representative descriptive evidence for England and 
Wales on revision for prosthetic joint infection (PJI) 
following knee replacements.
 ► Over 600 000 index primary replacements, 30 000 
index revision replacements and 8000 revision 
total replacements performed due to a diagnosis of 
infection are included in the analyses.
 ► Contemporary evidence regarding changes over 
time in the risk of revision for PJI, its burden, and 
the types of revision surgery used for managing PJI 
is provided.
 ► The diagnosis of PJI recorded in the registry is 
not validated against a recognised international 
standard and may therefore be subject to over-
reporting or under-reporting.
 ► Not all recorded revisions for PJI had an index 
primary or aseptic revision total knee replacement 
recorded in the National Joint Registry.
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of life and, if untreated, loss of the affected limb or 
death.1–3
Estimates of the incidence of PJI after primary knee 
replacement have a range between 0.85% in Germany, 
1.0% in the UK, 1.4% in Finland and 2.2% in the USA.4–7 
In a study from Finland, about 1.14% of patients had a 
PJI within 2 years of their primary knee replacement with 
a further 0.27% of patients presenting with PJI later than 
2 years after primary surgery.6 After aseptic revision and 
more complex knee replacement surgeries, infection 
rates may be considerably higher.8 There is a paucity of 
evidence from UK centres and the available studies are 
old and based on single-centre data.4 9
Bacteria adhere as biofilm to implants and 
periprosthetic tissues making the treatment of PJI diffi-
cult.10 Patients with PJI after knee replacement and their 
treating surgeons face complex and protracted treat-
ment pathways. Initial treatment may involve surgical 
debridement, antibiotics and implant retention (DAIR), 
particularly in early postoperative infections. However, 
about 45%–52% of patients receiving DAIR may subse-
quently need revision of their implants.11 Rates of 
revision of implants following treatment with a DAIR may 
be lower with strict selection criteria,12 but larger single-
centre cohort studies suggest the rate remains around 
20% by 2 years.13 Delays to effective infection control 
inherent in this process may lead to a poor postreplace-
ment outcome.14
For patients with acute PJI diagnosed before biofilm 
maturation occurs, DAIR with modular exchange is a 
reasonable treatment option but for the majority of 
patients outside of this window of opportunity, contempo-
rary management involves surgical revision with extensive 
debridement and antibiotic treatment with either imme-
diate implant replacement (single-stage) or delayed 
implant replacement (two-stage).
The two-stage revision procedure was the first 
method reported for treatment of PJI of the knee that 
aimed to restore a functioning, painless knee.15 The 
period between operations allows targeted antibiotic 
treatment and monitoring of clinical status and inflam-
matory markers. However, patients require two distinct 
planned major surgeries and a period of several months 
with limited knee function and protracted distress, 
concern and uncertainty.16 An alternate one-stage 
strategy was developed by the Endo-Klinik and its use 
reported from 1976.17 Key to the single-stage revision 
strategy is extensive debridement, identification of the 
infecting organisms and appropriate tailored antibiotic 
treatment.18
Pooled evidence from case series suggests similar rates 
of reinfection after each treatment.19 The decision to treat 
with a single-stage or two-stage procedure may be guided 
by microbiological tests, patient and surgical factors but 
ultimately the choice of revision method is largely that of 
the treating surgeon.2
The National Joint Registry (NJR) for England, Wales 
Northern Ireland and the Isle of Man is the largest joint 
replacement database in the world and has collected data 
since April 2003.20
We analysed this dataset to assess the burden of revision 
surgery for knee PJI between April 2003 and December 
2013. In this period, data were available from England 
and Wales. Our specific aims were to:
 ► Present the surgeon’s perspective by describing the 
prevalence rates of revision surgery for the treatment 
of knee PJI following primary and revision surgery for 
aseptic indications, and their time trends broken down 
by time from index surgery to revision for infection.
 ► Present the patient’s perspective by deriving cum-
ulative incidence functions by type of index surgery.
 ► Estimate the burden of revision surgery for knee 
PJI at a health service level by accounting for all of 
the registered revisions and re-revision surgeries 
performed for knee PJI.
MeThods
data source
In this observational study, we report analyses of data 
from the NJR.20 The registry was established in 2003 and 
includes details of primary and revision knee replacements 
performed in England and Wales. Data entry for Northern 
Ireland and the Isle of Man did not commence until 2013 
and 2015, respectively, and data linkage for those periods is 
limited, therefore they are excluded from this analysis.
Index surgeries and revision surgeries for PJI
We grouped procedures as index knee replacements 
and revision surgeries for treatment of knee PJI. Index 
surgeries included all primary procedures and all revision 
procedures performed for an indication other than infec-
tion. The index revision procedures have been labelled 
‘aseptic revision’ procedures to indicate they were not 
performed due to PJI. All index surgeries performed 
between 1 April 2003 and 31 December 2013 were 
included (to allow a minimum 12-month follow-up).
Information on microbiology results is not recorded in 
the NJR and infected index procedures were identified 
using subsequent revision performed for an indication of 
PJI. The diagnosis and treatment strategy for PJI is at the 
discretion of the surgeon according to local protocols 
and available information at the time of surgery. Revision 
surgeries performed as a consequence of PJI between 1 
April 2003 and 31 December 2014 were considered. Revi-
sions not performed for PJI but that were performed on a 
knee previously operated on due to PJI were not considered 
as index procedures, but were used alongside the revision 
and re-revision procedures for PJI to define the ‘burden of 
PJI.’ Non-surgical management of PJI and surgical proce-
dures where no revision or modular exchange of implants 
is performed are not recorded in the NJR.
Revision procedures are reported in the NJR as a 
single-stage, a stage 1 of a two-stage revision, a stage 2 of a 
two-stage revision procedure, a conversion to arthrodesis or 
an amputation. DAIR procedures with modular exchange 
are recorded in the NJR dataset as single-stage revision 
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procedures. To identify which procedures recorded as 
single-stage revisions were DAIRs with modular exchange as 
opposed to complete single-stage revisions where implants 
fixed to bone are also revised, the component level data were 
considered for the index and revision procedures. Implant 
component labels are compulsory for all NJR records, the 
minimum dataset forms also contain fields for components 
removed but this information is discretionary and limited 
to the brand removed, therefore does not allow component 
tracing unless a linked index procedure exists. Procedures 
were therefore defined on the basis of the data provided 
for components implanted at revision surgery. Procedures 
recorded as single-stage revisions where only modular 
components were added (termed ‘meniscal component’ in 
the minimum dataset) were defined as DAIRs with modular 
exchange. Those where implants fixed to bone were 
implanted (‘femoral component’, ‘tibial tray’ +/− ‘patella’) 
were defined as single-stage revisions. Debridements where 
the surgeon either elects to not exchange modular compo-
nents when they are present or where modular exchange 
is not possible (eg, with monoblock polyethylene tibial 
components) are not captured in the NJR.
Missing procedures
There were 2880 two-stage revision procedures recorded 
where the index surgery was a primary knee replacement; 
in 792 (27%) of these, only a stage 2 of a two-stage proce-
dure was recorded in the NJR. This was also observed 
for 154 (26%) of the 589 two-stage revision procedures 
following an index aseptic revision procedure. Patients 
with incompletely registered two-stage procedures did 
not differ from those with complete information in terms 
of gender, body mass index (BMI) and American Society 
of Anesthesiologists (ASA)physical status classification 
system grade (see online supplementary table 1). For 
index primary knee replacement, patients with incom-
plete information were on average 1 year older than those 
with complete information (p=0.05). For aseptic revision 
surgeries, no age difference was observed between the 
two groups.
For incomplete procedures, the date of the stage 1 
of a two-stage revision procedure was estimated. First 
we derived the relative weight of time elapsed between 
the index and stage 1 of a two-stage procedure by year 
and type of index surgery using patients with complete 
information: 100 × (length of timeindex surgery-1st stage/length 
of timeindex surgery-2nd stage). We applied these weights to the 
length of time observed between the index and stage 2 of 
a two-stage procedure for those with incomplete informa-
tion to obtain an estimate for the time between the index 
surgery and stage 1 of the revision surgery.
statistical analyses
Analyses were performed with Stata SE V.13.1 (StataCorp).
Surgeon perspective
Prevalence rates of index surgeries performed between 
2003 and 2013 and subsequently revised for infection 
between 2003 and 2014 were derived by year and type 
of index surgery. This provides a ‘surgeon’ perspec-
tive of revision for PJI by describing the proportion of 
knee replacements which required revision surgery 
for the management of infection. The prevalence 
rates were plotted by time from index surgery to revi-
sion for infection (≤3 months, 3–6 months, 6 months to 
1 year, 1–2 years, 2–3 years, 3–4 years and 5–6 years). For 
two-stage surgeries, the date of stage 1 of a two-stage revi-
sion was selected to indicate the date of revision for PJI. 
Log-linear regression, using the year of the index knee 
replacement as a continuous independent factor, was 
used to investigate overall linear trends between 2005 and 
2013. This period was selected as over 85% (proportion 
of procedure records submitted to the NJR compared 
with the levy returns for the number of implants sold) of 
knee replacements performed in 2005 and over 99% of 
those performed from 2007 onwards had been recorded 
in the NJR; prior to 2005, the data capture of the NJR 
was <75%.21 When evidence of a time trend was identified 
(year of surgery, p≤0.05), the year of surgery was reconsid-
ered as a categorical variable using 2005 as the reference 
period. Estimated relative risk and related 95% CI quanti-
fied the relative increase in prevalence rates between the 
period of interest and 2005.
Patient perspective
To move from a surgical perspective to a patient perspec-
tive, cumulative incidence functions22–24 were derived by 
type of index surgery (primary or aseptic revision). These 
provide the probability of being revised as a consequence 
of PJI within a specific time period following the index 
surgery while accounting for the time patients were at risk 
of being revised for a PJI and the competing risks of death 
and revision for an aseptic indication.
Healthcare service perspective
The overall ‘burden of revision surgery for knee PJI’ was 
analysed using all revision procedures performed between 
2003 and 2014 for an indication of PJI as well as any subse-
quent re-revision procedures for PJI or another indication.
Typically, knee replacement survivorship is 10 years 
or more following surgery,20 re-revision procedures 
performed for another indication than PJI during the 
observation period are therefore considered as a conse-
quence of the earlier management of PJI.
Revision procedures for an indication of PJI with no 
index procedure recorded in the NJR (n=3064, figure 1) 
and their re-revision procedures were also accounted. 
Contrary to the previous analyses in which index surgeries 
performed in 2014 and their revision procedures were 
not considered to allow for a minimum of 1 year postop-
erative follow-up, revisions for PJI relating to index knee 
replacements performed in 2014 (n=122) were included 
in this analysis.
The overall burden was reported by the year and type of 
revision surgery. Stage 1 of a two-stage revision and stage 2 
of a two-stage revision were considered as one procedure to 
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Table 1 Primary and aseptic revision knee replacement procedures revised for a knee prosthetic joint infection (PJI)
Year of index 
procedure
Index primary replacement Index aseptic revision replacement
Total, N
Revised 
for PJI, n
Prevalence rate per 
1000, 95% CI Total, N
Revised for 
PJI, n
Prevalence rate per 
1000, 95% CI
Total 679 010 3 659 5.39 (5.21 to 5.56) 33 920 717 21.14 (19.61 to 22.67)
2003 13 547 112 8.27 (6.74 to 9.79) 534 24 44.94 (27.37 to 62.52)
2004 27 706 184 6.64 (5.68 to 7.60) 1001 24 23.98 (14.50 to 33.45)
2005 41 848 314 7.50 (6.68 to 8.33) 1612 41 25.43 (17.75 to 33.12)
2006 49 482 346 6.99 (6.26 to 7.73) 2094 55 26.27 (19.42 to 33.12)
2007 66 618 471 7.07 (6.43 to 7.71) 2847 60 21.07 (15.80 to 26.35)
2008 73 859 443 6.00 (5.44 to 6.55) 3538 87 24.59 (19.49 to 29.69)
2009 75 612 465 6.15 (5.59 to 6.71) 3884 91 23.43 (18.67 to 28.19)
2010 78 276 423 5.40 (4.89 to 5.92) 4196 102 24.31 (19.65 to 28.97)
2011 81 795 378 4.62 (4.16 to 5.09) 4336 81 18.68 (14.65 to 22.71)
2012 85 161 341 4.00 (3.58 to 4.43) 5115 93 18.18 (14.52 to 21.84)
2013 85 106 182 2.14 (1.83 to 2.45) 4763 59 12.39 (9.25 to 15.53)
Figure 1 (A–C) Description of procedures recorded in the National Joint Registry (NJR).
avoid double counting. The same strategy was also used to 
account for multiple stage 1's of a two-stage revision proce-
dure.
resulTs
surgeon perspective
There were 679 010 primary and 33 920 aseptic revision 
knee replacements recorded in the NJR for England and 
Wales between April 2003 and December 2013 (table 1).
A total of 3659 patients required at least one revi-
sion surgery due to PJI (4004 procedures) following a 
primary knee replacement (figure 1A). A further 717 
patients required a subsequent revision for PJI (785 
procedures) following an aseptic revision knee replace-
ment (figure 1B). For 2918 patients who underwent 
revision for PJI (3187 procedures), no index surgery was 
recorded (figure 1C).
Of the primary knee replacements recorded in the 
NJR, 5.39/1000 (95% CI 5.21 to 5.56) were subsequently 
revised due to PJI (table 1). Of the aseptic revision knee 
replacements, 21.14/1000 (95% CI 19.61 to 22.67) were 
subsequently revised due to PJI.
Figure 2 shows trends in revision for PJI in the 2 years after 
primary knee replacement. Revision rates within 3 months 
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Figure 2 Prevalence (95% CI) of revision for prosthetic joint infection within 2 years of the index primary knee replacement.
Figure 3 Prevalence (95% CI) of revision for prosthetic joint infection within 2 years of the index aseptic revision knee 
replacement.
of the index procedure increased over time, with the 
prevalence rate in 2013 over twice that in 2005, rate ratio 
(RR) 2.46 (95% CI 1.15 to 5.25; time trend p<0.0001). No 
time trends for revision rates between 2005 and 2013 were 
apparent in the periods 3–6 months, 6 months to 1 year, and 
1–2 years. Other than the prevalence rate of revision for PJI 
between 5 and 6 years which decreased over time, RR 0.53 
(95% CI 0.33 to 0.86; time trend p=0.018), there was no 
evidence of time trends for the rates of late revision for PJI 
(see online  supplementary figure 1).
Trends in subsequent revision of aseptic revision knee 
replacements for PJI are shown in figure 3 and online 
supplementary figure 2. The prevalence of aseptic revi-
sions revised for PJI within 3 months of the procedure 
increased over time, RR 7.47 (95% CI 1.00 to 56.12; 
time trend p=0.001 for 2013 compared with 2006). No 
important differences were noted in the prevalence 
rates of revision for PJI performed at any time beyond 
3 months from the index revision surgery (all time trends, 
p value>0.1) with the exception of revision for infection 
between 2 and 3 years for which the rates decreased over 
time, RR 0.40 (95% CI  0.18 to 0.88; time trend p=0.008 for 
2011 compared with 2005).
Patient perspective
Figure 4 shows the incidence over time of revision for PJI 
in patients with an index primary or aseptic revision while 
accounting for the risk of death and revision for any indi-
cation other than PJI. The probability of revision for PJI 
at 1 year following a primary knee replacement 1.7/1000 
(95% CI 1.6 to 1.8) compared with 7.6/1000 (95% CI 6.8 
to 8.6) following an aseptic revision knee replacement. At 
2 years the probability was 3.2/1000 (95% CI 3.1 to 3.4) 
and 14.4/1000 (95% CI 13.1 to 15.7), respectively, and at 
5 years it was 5.6/1000 (95% CI 5.4 to 5.8) and 24.1/1000 
(95% CI 22.3 to 26.1), respectively. The probability of revi-
sion for infection within the first 10 years following primary 
knee replacement was 7.5/1000 (95% CI 7.2 to 7.8) and 
31.3/1000 (95% CI 28.1 to 24.9) following an aseptic revi-
sion.
healthcare service perspective
Table 2 summarises the revision surgeries for the manage-
ment of PJI and subsequent re-revisions (including 
repeated procedures to manage PJI and other revision 
procedures, see figure 1A–C) performed after primary 
and aseptic revision knee replacement by the year the 
(re-)revision was performed.
The absolute number of procedures performed as a 
consequence of PJI in England and Wales has increased 
from 378 in 2005 to 1048 in 2014, a relative increase 
of 2.8-fold. This is higher than the 2.1-fold increase in 
primary knee replacements over the same period, but 
similar to the 2.9 increase in aseptic revision surgeries 
between 2005 and 2013 (table 1).
Overall, 75% of revisions were conducted with a 
two-stage procedure but the use of single-stage revision 
for PJI has increased from 7.9% in 2005 to 18.8% in 2014. 
The median interval between stages in a two-stage revision 
following a primary index surgery was 99 days (25th–75th 
percentiles: 68, 156). A 101-day (67, 147) median interval 
was observed for two-stage revision performed to manage 
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Figure 4 Cumulative incidence function of revision for 
prosthetic joint infection following index primary and aseptic 
revision knee replacement.
Table 2 Revision procedures performed as a consequence of PJI by type and year of procedure*
Year of revision 
procedure Total, N DAIR, n (%) Single-stage, n (%) Two-stage, n (%) Other†, n (%)
Total 8587 408 (4.8) 1589 (18.5) 6456 (75.2) 134 (1.6)
2003 126 3 (2.4) 116 (92.1) 7 (05.6) 0 (0.0)
2004 236 3 (1.3) 59 (25.0) 171 (72.5) 3 (1.3)
2005 378 8 (2.1) 30 (07.9) 336 (88.9) 4 (1.1)
2006 485 11 (2.3) 49 (10.1) 419 (86.4) 6 (1.2)
2007 663 19 (2.9) 70 (10.6) 560 (84.5) 14 (2.1)
2008 783 29 (3.7) 124 (15.8) 615 (78.5) 15 (1.9)
2009 852 32 (3.8) 145 (17.0) 662 (77.7) 13 (1.5)
2010 931 38 (4.1) 178 (19.1) 707 (75.9) 8 (0.9)
2011 1004 51 (5.1) 187 (18.6) 748 (74.5) 18 (1.8)
2012 1035 58 (5.6) 200 (19.3) 754 (72.9) 23 (2.2)
2013 1046 61 (5.8) 234 (22.4) 732 (70.0) 19 (1.8)
2014 1048 95 (9.1) 197 (18.8) 745 (71.1) 11 (1.1)
*This table reports the revision procedures performed after any index surgery revised as a consequence of PJI including subsequent re-
revision procedures whether performed to manage an infection or not. It also includes the revision procedures performed between 2003 and 
2014 on 3064 patients with PJI but with no index procedure documented in the NJR.
†Conversion to arthrodesis or amputation.
DAIR, debridement, antibiotics and implant retention; NJR, National Joint Registry; PJI, prosthetic joint infection. 
PJI following an index aseptic revision surgery. The DAIR 
procedures represented around 5% of the total reported 
procedures and 9% of those reported in 2014. Other 
types of revision surgeries were rare and consisted mainly 
of arthrodesis (110 out of 134).
dIscussIon
This study is the largest to date investigating the treat-
ment of PJI after knee replacement. It includes 7 12 930 
primary and aseptic revision index procedures and 8247 
revision total knee replacements performed due to a 
diagnosis of PJI. We have shown that the prevalence and 
incidence rates of revision for PJI are higher following 
aseptic revision knee replacement than for primary knee 
replacement and that the prevalence of revision for PJI 
within 3 months of surgery has risen over time for primary 
and aseptic revision procedures. The total burden of 
treating PJI of the knee has risen substantially, with over 
1000 procedures performed per year from 2011 onwards, 
which mirrors the greater rise in aseptic revision surgery 
compared with primary knee replacements.20 From 
2005, we have identified an increased use of single-stage 
as compared with two-stage revision for PJI of the knee 
which appears to have plateaued at approximately 20%.
strengths and weaknesses
The NJR is an established, large, prospective, observa-
tional arthroplasty register with comprehensive coverage 
of procedures undertaken, which is reassuring in terms 
of the generalisability of the data generated by the study. 
The data have some limitations. The recording of PJI 
as an indication for surgery is according to the opinion 
of the treating surgeon at the time of surgery and, as 
such, the diagnosis has not necessarily been referenced 
against a gold standard set of criteria and hence may be 
subject to misdiagnosis. While the NJR now represents a 
mature dataset with long-term follow-up, there are still a 
substantial number of procedures undergoing revision 
knee replacement where there is no record of a linked 
index primary or revision knee replacement or where 
there is an incomplete set of procedures recorded for 
two-stage revision surgery. This may be a reflection of 
the high survivorship of knee replacement for 10 years 
or more following surgery,20 the fact that some PJI is 
acquired late and that not every case performed since 
2003 in England and Wales has been recorded in the 
NJR. Given there was no difference between patients with 
complete two-stage episodes recorded and those with 
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partial episodes recorded in terms of age, gender, BMI 
and ASA grade, we have assumed that the time interval 
of the former is generalisable to the latter, which may not 
be the case. The NJR does not capture information on 
microbiology results, non-surgical treatment of PJI and 
revision for PJI with implant retention but no modular 
exchange. Currently in the NJR, the only option to record 
DAIR procedures where modular exchange is performed 
is to record them as single-stage revision surgeries.25 
This complicates their differentiation from single-stage 
surgeries where the femoral and tibial components are 
revised. This represents a potential weakness of the data 
collection form as this may be subject to different inter-
pretation by surgeons, despite the fact that recording 
of procedures in which any component is removed or 
inserted is mandatory. We have used component level 
data for individual cases to identify DAIR procedures 
with modular exchange. A few single-stage revisions for 
PJI unlinked to an index procedure were considered 
as DAIRs in view of the components implanted (n=66). 
The capture of revision surgeries, in particular those 
performed for PJI, is also not perfect in arthroplasty regis-
tries26–29 and it is unclear how complete the capture of 
these procedures in the NJR is.
The annual burden of PJI with over 1000 procedures 
in recent years, while already high and expensive, is a 
conservative estimation and the cost of PJI considerable 
for the National Health Service.
comparison with other studies
Revision for infection is a rare complication of knee 
replacement. Our findings in this respect are consistent 
with previous studies from England and Wales4 9 although 
the reported prevalence rates were higher in previous 
studies (around 1% at 5 years following primary replace-
ment compared with 0.5% in our study). Our study was 
not contemporaneous with those studies (index surgeries 
performed between 1987 and 20019 or 1993 and 1996)4 
and the considered sample size in them was smaller 
(n=4788 and n=931). Evidence from other countries 
shows similar prevalence rates of revision for infection 
(rates ranging from 0.4% to 2.2%).5–7 30 31 Studies that 
report incidence rates typically include any type of oper-
ations for the management of infection (not just those 
where implants are removed or changed) and this may 
be why they show higher rates (0.9%–1.4% between 1 and 
5 years postoperatively).6 32
We have demonstrated a substantial time trend of an 
increased risk of revision for PJI within the first 3 months 
of an index primary or aseptic revision knee replace-
ment being performed. This phenomenon is likely to 
be multifactorial. Factors that could lead to an increased 
diagnosis of PJI in this period and hence increased risk of 
revision include the increased accuracy of tests available 
to clinicians for the diagnosis of PJI,33 coupled with more 
rapid diagnosis and/or treatment in specialist centres, 
the increased risk factors for PJI among the popula-
tion undergoing knee replacement population (such as 
elevated body mass index)34 and increased bed occupancy 
within the healthcare setting in which these procedures 
were performed.35 There may be a trend towards the use 
of revision surgery to manage PJI rather than suppressive 
treatment with antibiotics but we cannot comment on this 
as non-surgical management of PJI is beyond the scope 
of this study. There have been similar findings in other 
countries that could not be accounted for by risk factors 
recorded in those registries, suggesting this trend could 
reflect an actual general increase in the risk of PJI.36 It 
is interesting to note from our results that there has not 
been a relative increase in the use of DAIRs with modular 
exchanges in the NJR to explain this phenomenon.
We have shown a greater incidence of revision for 
PJI following aseptic revision knee replacement (3.1% 
at 10 years) compared with primary knee replacement 
(0.8% at 10 years) consistent with the findings of previous 
cohort studies.4 31 32 37–39 Previous surgery is a known risk 
factor for PJI,40 this may be because of further bacterial 
contamination or increased length of surgery. Revision 
knee replacement tends to be performed in a popula-
tion with increased host41 and procedure risk factors 
for infection or further revision42 and involve the intro-
duction of a greater volume of prosthetic material and 
additional adjuncts such as bone graft that may present 
a favourable environment for bacterial colonisation and 
subsequent PJI.43
Implications for clinicians and policymakers
The current rate of surgical revision of PJI of the knee 
stands at approximately 1000 cases per year across the 
NJR. This represents a significant healthcare burden 
which has more than doubled over the last decade, 
exceeding the rate of increase in primary knee replace-
ments. The cost of revision knee replacement due to PJI 
is more than three times that of primary knee replace-
ment and over twice that of aseptic revision.44 In the 
National Health Service, the costs associated with revi-
sion knee replacement due to PJI have been shown to 
be in excess of £30 000 per case, greater than other indi-
cations for revision,45 even before accounting for costs 
associated with litigation. Single-stage revision offers 
an advantage over the two-stage approach in terms of 
both patient-derived and surgeon-derived utility values 
in both the short term and long term in the hip46 and 
may be associated with superior functional outcomes in 
the knee,47 suggesting this increased burden could be 
ameliorated by the increased use of a single-stage revi-
sion strategy.
unanswered questions and future research
The observed trend of an increase in the risk of infec-
tion in the first 3 months following primary and aseptic 
revision total knee replacement is not currently well 
understood. Identification of the risk factors associated 
with this phenomenon and modifiable risk factors for 
PJI may help reduce this risk. Although the use of single-
stage revision knee replacement for the treatment of PJI 
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has increased to approximately 20%, given the current 
evidence base shows equivalent reinfection rates 
following single-stage compared with two-stage revision 
surgery for PJI,19 48 it might be possible that the propor-
tion of patients treated with single-stage surgery taking 
account of patient, surgeon and operative factors could 
be further increased. Given the increasing burden of 
treating PJI, this may help ameliorate the increase in 
resources that will otherwise be required to treat this 
condition.49 In the absence of data from randomised 
controlled trials or other direct comparisons, we plan 
further analyses of the NJR data which will compare 
outcomes after one-stage and two-stage methods with 
robust adjustment for key patient and surgical factors. 
Such evidence will support the decision-making process 
in the planning and treatment of patients with PJI after 
knee replacement.
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